Bradykinin inhibits renal fibrosis by increasing the NO production, suppression of TGFβ1 expression and mitogen-activated protein kinase (ERK and p38) phosphorylation (Hagiwara et al., 2004[25]). The gene discussed is TGFB1; the disease is renal fibrosis.